Toxicity and outcome of definitive chemoradiotherapy for elderly patients with esophageal cancer

被引:0
|
作者
Iovashvili, A. [1 ]
Chkhaidze, L. [2 ]
Natelauri, E. [2 ]
Sokurashvili, B. [3 ]
Mariamidze, E. [4 ]
Kacheishvili, N. [5 ]
Jeremic, B. [6 ]
Kiladze, I. [1 ]
机构
[1] Caucasus Med Ctr, Evex Hosp, Tbilisi, Georgia
[2] Evex Hosp, Krystyna Kiel Oncol Ctr, Kutaisi, Georgia
[3] Eristavi Natl Ctr Surg, Tbilisi, Georgia
[4] Todua Clin, Tbilisi, Georgia
[5] Mardaleishvili Med Ctr, Tbilisi, Georgia
[6] Univ Kragujevac, Fac Med, Kragujevac, Serbia
关键词
D O I
10.1016/j.annonc.2023.04.075
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-19
引用
收藏
页码:S20 / S20
页数:1
相关论文
共 50 条
  • [41] EMR as salvage treatment for patients with locoregional failure of definitive chemoradiotherapy for esophageal cancer
    Hattori, S
    Muto, M
    Ohtsu, A
    Boku, N
    Manabe, T
    Doi, T
    Ishikura, S
    Yoshida, S
    GASTROINTESTINAL ENDOSCOPY, 2003, 58 (01) : 65 - 70
  • [42] Endoscopic Management of Esophageal Cancer After Definitive Chemoradiotherapy
    Sajneet K. Khangura
    Bruce D. Greenwald
    Digestive Diseases and Sciences, 2013, 58 : 1477 - 1485
  • [43] Salvage esophagectomy after definitive chemoradiotherapy for esophageal cancer
    Oki, E.
    Morita, M.
    Kakeji, Y.
    Ikebe, M.
    Sadanaga, N.
    Egasira, A.
    Nishida, K.
    Koga, T.
    Ohata, M.
    Honboh, T.
    Yamamoto, M.
    Baba, H.
    Maehara, Y.
    DISEASES OF THE ESOPHAGUS, 2007, 20 (04): : 301 - 304
  • [44] Will definitive chemoradiotherapy be a new normal for patients with resectable locally advanced esophageal cancer?
    Hiroya Takeuchi
    Esophagus, 2020, 17 : 363 - 364
  • [45] Neoadjuvant Versus Definitive Concurrent Chemoradiotherapy In Stage III Esophageal Cancer Patients
    Chen, H. L.
    Chou, Y. H.
    Lee, Y.
    Tseng, H. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E656 - E656
  • [46] Retrospective Analysis of Definitive Chemoradiotherapy With FOLFOX in Patients With Esophageal Cancer Intolerant to Cisplatin
    Yada, Mayu
    Yamamoto, Shun
    Honma, Yoshitaka
    Hirano, Hidekazu
    Okita, Natsuko
    Shoji, Hirokazu
    Iwasa, Satoru
    Takashima, Atsuo
    Nagahara, Akihito
    Kato, Ken
    IN VIVO, 2024, 38 (02): : 761 - 766
  • [47] Endoscopic Management of Esophageal Cancer After Definitive Chemoradiotherapy
    Khangura, Sajneet K.
    Greenwald, Bruce D.
    DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (06) : 1477 - 1485
  • [48] Definitive concurrent chemoradiotherapy in patients of synchronous esophageal and head and neck cancer in Vietnam
    Hoang, G. Ngoc
    Nguyen, H. Thi
    Phuong, N.
    ANNALS OF ONCOLOGY, 2024, 35 : S1359 - S1359
  • [49] The Efficacy and Safety of Definitive Concurrent Chemoradiotherapy for Esophageal Cancer
    Dreyfuss, A.
    Barsky, A. R.
    Plastaras, J. P.
    Ben-Josef, E.
    Eads, J.
    Kucharczuk, J.
    Williams, N. N.
    Karasic, T. B.
    Metz, J. M.
    Wojcieszynski, A. P., Jr.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E663 - E663
  • [50] Salvage surgery after definitive chemoradiotherapy for esophageal cancer
    Nakamura T.
    Hayashi K.
    Ota M.
    Narumiya K.
    Eguchi R.
    Ide H.
    Takasaki K.
    Esophagus, 2005, 2 (3) : 123 - 128